BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34435264)

  • 1. Chromatin Modifications in 22q11.2 Deletion Syndrome.
    Zhang Z; Shi L; Song L; Maurer K; Zhao X; Zackai EH; McGinn DE; Crowley TB; McGinn DMM; Sullivan KE
    J Clin Immunol; 2021 Nov; 41(8):1853-1864. PubMed ID: 34435264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
    Iijima T; Jojima T; Hosonuma S; Ohhira E; Tomaru T; Kogai T; Usui I; Aso Y
    Endocr J; 2021 Oct; 68(10):1187-1195. PubMed ID: 33980771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases.
    Crowley TB; Campbell IM; Liebling EJ; Lambert MP; Levitt Katz LE; Heimall J; Bailey A; McGinn DE; McDonald McGinn DM; Sullivan KE
    J Allergy Clin Immunol; 2022 Jan; 149(1):445-450. PubMed ID: 34144109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome.
    Piliero LM; Sanford AN; McDonald-McGinn DM; Zackai EH; Sullivan KE
    Blood; 2004 Feb; 103(3):1020-5. PubMed ID: 14525774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome.
    Ferrando-Martínez S; Lorente R; Gurbindo D; De José MI; Leal M; Muñoz-Fernández MA; Correa-Rocha R
    J Pediatr; 2014 Apr; 164(4):882-9. PubMed ID: 24461789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic defects in 22q11.2 deletion syndrome.
    McLean-Tooke A; Barge D; Spickett GP; Gennery AR
    J Allergy Clin Immunol; 2008 Aug; 122(2):362-7, 367.e1-4. PubMed ID: 18485468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated Maturation, Exhaustion, and Senescence of T cells in 22q11.2 Deletion Syndrome.
    Smetanova J; Milota T; Rataj M; Bloomfield M; Sediva A; Klocperk A
    J Clin Immunol; 2022 Feb; 42(2):274-285. PubMed ID: 34716533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell development in chromosome 22q11.2 deletion syndrome.
    Derfalvi B; Maurer K; McDonald McGinn DM; Zackai E; Meng W; Luning Prak ET; Sullivan KE
    Clin Immunol; 2016 Feb; 163():1-9. PubMed ID: 26689329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
    Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.
    Eberle P; Berger C; Junge S; Dougoud S; Büchel EV; Riegel M; Schinzel A; Seger R; Güngör T
    Clin Exp Immunol; 2009 Feb; 155(2):189-98. PubMed ID: 19040613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome.
    Montin D; Marolda A; Licciardi F; Robasto F; Di Cesare S; Ricotti E; Ferro F; Scaioli G; Giancotta C; Amodio D; Conti F; Giardino G; Leonardi L; Ricci S; Volpi S; Baselli LA; Azzari C; Bossi G; Consolini R; Dellepiane RM; Duse M; Gattorno M; Martire B; Putti MC; Soresina A; Plebani A; Ramenghi U; Martino S; Pignata C; Cancrini C
    J Allergy Clin Immunol Pract; 2019; 7(7):2369-2376. PubMed ID: 30922987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Pierdominici M; Mazzetta F; Caprini E; Marziali M; Digilio MC; Marino B; Aiuti A; Amati F; Russo G; Novelli G; Pandolfi F; Luzi G; Giovannetti A
    Clin Exp Immunol; 2003 May; 132(2):323-31. PubMed ID: 12699424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of thymocyte commitment to regulatory T cell lineage in thymus of healthy subjects and patients with 22q11.2 deletion syndrome.
    Borna S; Dejene B; Lakshmanan U; Schulze J; Weinberg K; Bacchetta R
    Front Immunol; 2023; 14():1088059. PubMed ID: 37006241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Live Vaccine in Children with DiGeorge/22q11.2 Deletion Syndrome].
    Miranda M; Martins AT; Carvalho S; Serra-Caetano A; Esteves I; Marques JG
    Acta Med Port; 2019 Aug; 32(7-8):514-519. PubMed ID: 31445531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.
    Kanaya Y; Ohga S; Ikeda K; Furuno K; Ohno T; Takada H; Kinukawa N; Hara T
    Clin Exp Immunol; 2006 Apr; 144(1):85-93. PubMed ID: 16542369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome).
    Jawad AF; Prak EL; Boyer J; McDonald-McGinn DM; Zackai E; McDonald K; Sullivan KE
    J Clin Immunol; 2011 Dec; 31(6):927-35. PubMed ID: 21863400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome.
    Suksawat Y; Sathienkijkanchai A; Veskitkul J; Jirapongsananuruk O; Visitsunthorn N; Vichyanond P; Pacharn P
    J Clin Immunol; 2017 May; 37(4):375-382. PubMed ID: 28429103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
    Kuo CY; Signer R; Saitta SC
    Curr Allergy Asthma Rep; 2018 Oct; 18(12):75. PubMed ID: 30377837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome).
    Finocchi A; Di Cesare S; Romiti ML; Capponi C; Rossi P; Carsetti R; Cancrini C
    Pediatr Allergy Immunol; 2006 Aug; 17(5):382-8. PubMed ID: 16846458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.
    McLean-Tooke A; Barge D; Spickett GP; Gennery AR
    Scand J Immunol; 2011 Jun; 73(6):577-85. PubMed ID: 21323691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.